Talphera Inc (TLPH)

$0.87 0.00 (-0.35%)
Market Cap 44.56M
Revenue (ttm) 0.00
Net Income (ttm) -13.00M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 436,555
Avg Vol 360,148
Day's Range N/A - N/A
Shares Out 46.61M
Stochastic %K 5%
Beta 0.30
Analysts Strong Sell
Price Target $3.25

Company Profile

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, a nafamostat formulation for direct IV infusion as an investigational product for various indications, such as antiviral,...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 650 216 3500
Address:
1850 Gateway Drive, Suite 175, San Mateo, United States
nazzangr
nazzangr Feb. 3 at 10:14 PM
$TLPH yet another study shows…. https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Comparison_of_Anticoagulant_Effects_of_Nafamostat_Mesilate_and_Heparin_in_Continuous_Renal_Replacement_Therapy_for_Patients_with_High_Bleeding_Risk_A_Meta-_Analysis_Systemic_Review/31227931
0 · Reply
Crandaddy01
Crandaddy01 Feb. 3 at 3:48 PM
$TLPH
0 · Reply
Yoda896
Yoda896 Feb. 3 at 3:12 PM
$TLPH I'm still hoping that they finished enrolling 35 patients, and surpassed it. But, they're waiting till the CC to announce it. Or, they're waiting for the stock to go down to a certain level, and then announce it. When the announcement is made, a milestone, the next portion of investment is going to be made by the two funds and probably by $CRMD. Those people may not be inclined to buy at value much higher than the price they paid last time ($0.55?). They probably want to pay only about $0.75. So, it's possible the price will go down to about $0.75, then the stock purchase deal will be done, then the milestone will be announced (35 or more have been enrolled), and finally the stock purchases will be filed with the SEC and made public. You may think that this scenario doesn't make sense. But, I'm guessing that the alternative makes much less sense.
1 · Reply
firedupinvestors
firedupinvestors Feb. 3 at 12:17 PM
$TLPH chaces we are going back to 50 pennies.
0 · Reply
greetingsoftheday
greetingsoftheday Feb. 2 at 11:13 PM
$CRMD The big wrinkle from the buy back is it very strongly suggests we aren't going to attempt to buyout $TLPH as a whole entity. My guess is Joe tries to strike a license deal (depending on whenever they can actually get their data, IDK what the hell TLPH is doing with their trial) if data is good with an upfront payment plus percentage of sales to TLPH. If someone from the clouds is willing to overpay for TLPH as a whole or the drug then so be it, CRMD makes out in the sale with how many shares they/we own. Of everything with the stock buy back plan this as an investor this alone to me is a massive net positive. I couldn't handle more dilution to buyout TLPH, I just don't think it would be prudent at this point.
1 · Reply
firedupinvestors
firedupinvestors Feb. 2 at 9:59 PM
$TLPH out of this crap.
0 · Reply
firedupinvestors
firedupinvestors Feb. 2 at 9:33 PM
$TLPH well , looks like I am out. Stop loss. Not buying back in. Poor investment.
0 · Reply
BigTpain
BigTpain Feb. 2 at 9:08 PM
$TLPH .......... OUCH!
1 · Reply
AlwaysRational
AlwaysRational Feb. 2 at 7:59 PM
$TLPH Got out earlier today with a tiny loss. I thought we'd see it hold at $1, but now that it's not, I expect a bleed down to at least .70, if not lower.
0 · Reply
Burning_Cash
Burning_Cash Feb. 2 at 5:54 PM
$TLPH Keeps bleeding day after day… Don’t have a big position, so I’ll just hold and see what happens.
0 · Reply
Latest News on TLPH
Talphera, Inc. (TLPH) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 7:11 PM EST - 2 months ago

Talphera, Inc. (TLPH) Q3 2025 Earnings Call Transcript

Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update

Nov 12, 2025, 4:05 PM EST - 2 months ago

Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update

CRMD

Talphera to Host Third Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, November 12, 2025

Nov 5, 2025, 4:05 PM EST - 3 months ago

Talphera to Host Third Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, November 12, 2025

Talphera Announces the Appointment of Joe Todisco to Board of Directors

Oct 21, 2025, 8:30 AM EDT - 3 months ago

Talphera Announces the Appointment of Joe Todisco to Board of Directors

CorMedix Announces Strategic Minority Investment in Talphera

Sep 8, 2025, 8:30 AM EDT - 5 months ago

CorMedix Announces Strategic Minority Investment in Talphera

CRMD

Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market

Sep 8, 2025, 8:30 AM EDT - 5 months ago

Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market

CRMD

Talphera Announces Achievement of 17 Patient Enrollment Milestone in NEPHRO CRRT Pivotal Trial

Aug 25, 2025, 8:30 AM EDT - 5 months ago

Talphera Announces Achievement of 17 Patient Enrollment Milestone in NEPHRO CRRT Pivotal Trial

Talphera, Inc. (TLPH) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 9:10 PM EDT - 6 months ago

Talphera, Inc. (TLPH) Q2 2025 Earnings Call Transcript

Talphera Announces Second Quarter 2025 Financial Results and Provides Corporate Update

Aug 14, 2025, 4:05 PM EDT - 6 months ago

Talphera Announces Second Quarter 2025 Financial Results and Provides Corporate Update

Talphera to Host Second Quarter Financial Results and Corporate Update Call and Webcast on Thursday, August 14, 2025

Aug 7, 2025, 4:35 PM EDT - 6 months ago

Talphera to Host Second Quarter Financial Results and Corporate Update Call and Webcast on Thursday, August 14, 2025

Talphera, Inc. (TLPH) Q1 2025 Earnings Call Transcript

May 14, 2025, 9:01 PM EDT - 9 months ago

Talphera, Inc. (TLPH) Q1 2025 Earnings Call Transcript

Talphera Announces First Quarter 2025 Financial Results and Provides Corporate Update

May 14, 2025, 4:05 PM EDT - 9 months ago

Talphera Announces First Quarter 2025 Financial Results and Provides Corporate Update

Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 14, 2025

May 7, 2025, 4:05 PM EDT - 9 months ago

Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 14, 2025

Talphera, Inc. (TLPH) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 6:33 PM EDT - 11 months ago

Talphera, Inc. (TLPH) Q4 2024 Earnings Call Transcript

Talphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Mar 31, 2025, 4:05 PM EDT - 11 months ago

Talphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Talphera Announces Agreement with the FDA to Reduce the NEPHRO CRRT Study Size to 70 Patients From 166 and a Private Placement Financing Priced At-the Market of up to $14.8 Million

Mar 31, 2025, 8:30 AM EDT - 11 months ago

Talphera Announces Agreement with the FDA to Reduce the NEPHRO CRRT Study Size to 70 Patients From 166 and a Private Placement Financing Priced At-the Market of up to $14.8 Million

Talphera to Host Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update Call and Webcast on Monday, March 31, 2025

Mar 26, 2025, 4:38 PM EDT - 11 months ago

Talphera to Host Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update Call and Webcast on Monday, March 31, 2025

Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study

Jan 14, 2025, 8:30 AM EST - 1 year ago

Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study

Talphera, Inc. (TLPH) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 6:43 PM EST - 1 year ago

Talphera, Inc. (TLPH) Q3 2024 Earnings Call Transcript

Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 13, 2024, 4:05 PM EST - 1 year ago

Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update

Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024

Nov 6, 2024, 4:05 PM EST - 1 year ago

Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024

Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

Oct 8, 2024, 4:54 PM EDT - 1 year ago

Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

Talphera to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Sep 5, 2024, 4:15 PM EDT - 1 year ago

Talphera to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Talphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal Circuit

Aug 19, 2024, 8:30 AM EDT - 1 year ago

Talphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal Circuit

Talphera, Inc. (TLPH) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 6:39 PM EDT - 1 year ago

Talphera, Inc. (TLPH) Q2 2024 Earnings Call Transcript

Talphera Announces Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 14, 2024, 4:01 PM EDT - 1 year ago

Talphera Announces Second Quarter 2024 Financial Results and Provides Corporate Update

Talphera to Host Second Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, August 14, 2024

Aug 5, 2024, 4:05 PM EDT - 1 year ago

Talphera to Host Second Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, August 14, 2024

Talphera Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

May 20, 2024, 5:25 PM EDT - 1 year ago

Talphera Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Talphera to Participate at A.G.P. Virtual Healthcare Conference

May 16, 2024, 5:45 PM EDT - 1 year ago

Talphera to Participate at A.G.P. Virtual Healthcare Conference

Talphera, Inc. (TLPH) Q1 2024 Earnings Call Transcript

May 14, 2024, 6:21 PM EDT - 1 year ago

Talphera, Inc. (TLPH) Q1 2024 Earnings Call Transcript

Talphera Announces First Quarter 2024 Financial Results and Provides Corporate Update

May 14, 2024, 4:05 PM EDT - 1 year ago

Talphera Announces First Quarter 2024 Financial Results and Provides Corporate Update

Talphera to Host First Quarter 2024 Financial Results Call and Webcast on Tuesday, May 14, 2024

May 2, 2024, 4:15 PM EDT - 1 year ago

Talphera to Host First Quarter 2024 Financial Results Call and Webcast on Tuesday, May 14, 2024

Talphera, Inc. (TLPH) Q4 2023 Earnings Call Transcript

Mar 6, 2024, 9:48 PM EST - 2 years ago

Talphera, Inc. (TLPH) Q4 2023 Earnings Call Transcript

Talphera Announces Fourth Quarter 2023 Financial Results and Provides Corporate Update

Mar 6, 2024, 4:05 PM EST - 2 years ago

Talphera Announces Fourth Quarter 2023 Financial Results and Provides Corporate Update

Talphera Announces Reduction in Size of its Board of Directors from Ten to Seven Members

Mar 1, 2024, 7:30 AM EST - 2 years ago

Talphera Announces Reduction in Size of its Board of Directors from Ten to Seven Members

Talphera to Host Fourth Quarter and Full-Year 2023 Financial Results Call and Webcast on March 6, 2024

Feb 26, 2024, 4:15 PM EST - 2 years ago

Talphera to Host Fourth Quarter and Full-Year 2023 Financial Results Call and Webcast on March 6, 2024

Talphera Announces $26 Million Capital Commitment Through a Combination of a Non-Dilutive Royalty Monetization and Equity Offering

Jan 18, 2024, 8:30 AM EST - 2 years ago

Talphera Announces $26 Million Capital Commitment Through a Combination of a Non-Dilutive Royalty Monetization and Equity Offering

nazzangr
nazzangr Feb. 3 at 10:14 PM
$TLPH yet another study shows…. https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Comparison_of_Anticoagulant_Effects_of_Nafamostat_Mesilate_and_Heparin_in_Continuous_Renal_Replacement_Therapy_for_Patients_with_High_Bleeding_Risk_A_Meta-_Analysis_Systemic_Review/31227931
0 · Reply
Crandaddy01
Crandaddy01 Feb. 3 at 3:48 PM
$TLPH
0 · Reply
Yoda896
Yoda896 Feb. 3 at 3:12 PM
$TLPH I'm still hoping that they finished enrolling 35 patients, and surpassed it. But, they're waiting till the CC to announce it. Or, they're waiting for the stock to go down to a certain level, and then announce it. When the announcement is made, a milestone, the next portion of investment is going to be made by the two funds and probably by $CRMD. Those people may not be inclined to buy at value much higher than the price they paid last time ($0.55?). They probably want to pay only about $0.75. So, it's possible the price will go down to about $0.75, then the stock purchase deal will be done, then the milestone will be announced (35 or more have been enrolled), and finally the stock purchases will be filed with the SEC and made public. You may think that this scenario doesn't make sense. But, I'm guessing that the alternative makes much less sense.
1 · Reply
firedupinvestors
firedupinvestors Feb. 3 at 12:17 PM
$TLPH chaces we are going back to 50 pennies.
0 · Reply
greetingsoftheday
greetingsoftheday Feb. 2 at 11:13 PM
$CRMD The big wrinkle from the buy back is it very strongly suggests we aren't going to attempt to buyout $TLPH as a whole entity. My guess is Joe tries to strike a license deal (depending on whenever they can actually get their data, IDK what the hell TLPH is doing with their trial) if data is good with an upfront payment plus percentage of sales to TLPH. If someone from the clouds is willing to overpay for TLPH as a whole or the drug then so be it, CRMD makes out in the sale with how many shares they/we own. Of everything with the stock buy back plan this as an investor this alone to me is a massive net positive. I couldn't handle more dilution to buyout TLPH, I just don't think it would be prudent at this point.
1 · Reply
firedupinvestors
firedupinvestors Feb. 2 at 9:59 PM
$TLPH out of this crap.
0 · Reply
firedupinvestors
firedupinvestors Feb. 2 at 9:33 PM
$TLPH well , looks like I am out. Stop loss. Not buying back in. Poor investment.
0 · Reply
BigTpain
BigTpain Feb. 2 at 9:08 PM
$TLPH .......... OUCH!
1 · Reply
AlwaysRational
AlwaysRational Feb. 2 at 7:59 PM
$TLPH Got out earlier today with a tiny loss. I thought we'd see it hold at $1, but now that it's not, I expect a bleed down to at least .70, if not lower.
0 · Reply
Burning_Cash
Burning_Cash Feb. 2 at 5:54 PM
$TLPH Keeps bleeding day after day… Don’t have a big position, so I’ll just hold and see what happens.
0 · Reply
firedupinvestors
firedupinvestors Feb. 2 at 2:26 PM
$TLPH putting a stop loss in at .90. don't want to ride it down to .50. Boom boom boom how low do we go.
0 · Reply
Noname2022
Noname2022 Feb. 2 at 2:17 PM
$TLPH wonder how this will respond…
1 · Reply
nazzangr
nazzangr Jan. 30 at 6:59 PM
$TLPH will something big come?
0 · Reply
Kenan33y
Kenan33y Jan. 30 at 5:50 PM
$TLPH AIGH Capital Management LLC (Orin Hirschman) 4,454,545.00 -> 4,661,502.00 https://www.sec.gov/Archives/edgar/data/1427925/000149315225021361/xslSCHEDULE_13G_X01/primary_doc.xml https://www.sec.gov/Archives/edgar/data/1427925/000149315226004392/xslSCHEDULE_13G_X01/primary_doc.xml
1 · Reply
Hype2
Hype2 Jan. 30 at 9:06 AM
$TLPH Back to fifty cents soon.
0 · Reply
BigTpain
BigTpain Jan. 29 at 8:37 PM
$TLPH at the rate this is trading here is my prediction exactly one year from now: 52 week low $1.00 52 week high $1.00
1 · Reply
Miketj
Miketj Jan. 29 at 8:15 PM
$TLPH 😴💤
0 · Reply
Brunoez
Brunoez Jan. 29 at 7:49 PM
$TLPH It's been about 11 weeks since the Earnings Call on November 12, 2025 in which the CEO stated that enrollment was "Well beyond... 17". Logic would suggest that even at one new enrollment per week, we should be getting close to 35. This is also taking into consideration the expansion of the enrollment sites. Does logic apply here??
2 · Reply
Crandaddy01
Crandaddy01 Jan. 29 at 3:05 PM
$TLPH
0 · Reply
AlwaysRational
AlwaysRational Jan. 28 at 7:41 PM
$TLPH There sure are a lot of shares being traded for the price to stay essentially unchanged. Perhaps some quiet accumulation is taking place.
0 · Reply
AlwaysRational
AlwaysRational Jan. 27 at 6:18 PM
$TLPH This is getting pinned right the $1 mark. Interesting.
0 · Reply
_nic
_nic Jan. 27 at 10:37 AM
$TLPH whats going on here?
2 · Reply